Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue

Core Viewpoint - Cosmos Health Inc. continues to experience operational growth and infrastructure expansion through its subsidiary Cosmofarm, particularly in the pharmaceutical distribution sector in Greece [1]. Group 1: Customer Growth and Financial Performance - In 2025, Cosmofarm added nearly 100 new pharmacy customers, resulting in a 20% increase in its active customer base [2]. - Annual revenue per customer increased by approximately 12%, while profitability per customer improved by around 14%, attributed to enhanced route density and optimized order execution [2]. - Management anticipates that customer growth will continue at similar or higher rates in 2026 based on current onboarding activity and demand trends [2]. Group 2: Infrastructure and Automation Investments - Cosmofarm introduced three new delivery routes in the Attica region to enhance service quality and last-mile delivery performance [3]. - The company has made multi-million dollar investments in automation and logistics infrastructure, including advanced robotic systems for procurement and order fulfillment [4]. - A capital investment program of approximately $1 million is currently underway to expand robotic capacity and throughput [4]. Group 3: Revenue Potential and Operational Efficiency - The expanded ROWA and A-frame robotic picking line is expected to materially increase processing capacity and support an incremental annual revenue potential of approximately $40 million [7]. - The company is upgrading its 29,000-square-foot property in Athens to modernize office space and enhance distribution capabilities [8]. - CEO Greg Siokas emphasized that ongoing investments in automation will significantly expand capacity and support sustainable growth and long-term value creation for Cosmos Health [10].